DrugPatentWatch Database Preview
TOSYMRA Drug Profile
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
Which patents cover Tosymra, and when can generic versions of Tosymra launch?
Tosymra is a drug marketed by Upsher Smith Labs and is included in one NDA. There are six patents protecting this drug.
This drug has forty-six patent family members in fourteen countries.
The generic ingredient in TOSYMRA is sumatriptan. There are twenty-four drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the sumatriptan profile page.
US ANDA Litigation and Generic Entry Outlook for Tosymra
A generic version of TOSYMRA was approved as sumatriptan by LANNETT CO INC on January 20th, 2020.
Summary for TOSYMRA
| International Patents: | 46 |
| US Patents: | 6 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for TOSYMRA |
| DailyMed Link: | TOSYMRA at DailyMed |
Pharmacology for TOSYMRA
| Drug Class | Serotonin-1b and Serotonin-1d Receptor Agonist |
| Mechanism of Action | Serotonin 1d Receptor Agonists Serotonin 1b Receptor Agonists |
US Patents and Regulatory Information for TOSYMRA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Upsher Smith Labs | TOSYMRA | sumatriptan | SPRAY;NASAL | 210884-001 | Jan 25, 2019 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Upsher Smith Labs | TOSYMRA | sumatriptan | SPRAY;NASAL | 210884-001 | Jan 25, 2019 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Upsher Smith Labs | TOSYMRA | sumatriptan | SPRAY;NASAL | 210884-001 | Jan 25, 2019 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Upsher Smith Labs | TOSYMRA | sumatriptan | SPRAY;NASAL | 210884-001 | Jan 25, 2019 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| Upsher Smith Labs | TOSYMRA | sumatriptan | SPRAY;NASAL | 210884-001 | Jan 25, 2019 | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for TOSYMRA
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 2013505924 | Start Trial |
| South Africa | 201202168 | Start Trial |
| Denmark | 2381773 | Start Trial |
| Japan | 5752048 | Start Trial |
| Spain | 2667248 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
